australian healthcare

The reset has created winners and losers. From small caps to global leaders, four experts share where they see value emerging in healthcare.

One Australian healthcare company has quietly bucked the trend in 2025 and is up over 500% in a year.

Healthcare has been on life support throughout 2025, but there's signs of revival. Here are two ASX stocks that are looking healthy.

ASX healthcare’s been flatlining, could a recovery be on the cards? Two top investors name the stocks they think could revive the sector.

Deep expertise, high conviction investing, in some of the most exciting and innovative healthcare companies in the world.

Specialist expertise, months of due dilligence, and high conviction investments - KP Rx's formula for healthcare growth investing.

With the ability to offset the impact of tariffs and strong historical performance in tough times, the health sector could be one to watch.

We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.

Earnings may have bottomed out and there's hope in the air this reporting season, according to FNArena's Rudi Filapek-Vandyck

This $60m ASX-listed biotech, with a cutting-edge pipeline of transformative therapies, stands at a key inflection point for value creation.